Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ethical Architecture and Scientific Partnership: The Enduring Role of the Laboratory Animal Veterinarian.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026

Same author

Evaluation of Transport Time on Stress Biomarkers in Pigs.

Veterinary medicine and science·2025

Same author

AALAS Journal Updates for Authors.

Comparative medicine·2025

Same author

Protection of Rabbits Against Colonization and Morbidity Associated With Toxigenic <i>Pasteurella multocida</i> by Immunization With Inactivated Heat-labile Toxin.

In vivo (Athens, Greece)·2024

Same author

The ARRIVE 2.0 Guidelines: Importance and Full Adoption by AALAS Journals.

Comparative medicine·2024

Same author

The ARRIVE 2.0 Guidelines: Importance and Full Adoption by AALAS Journals.

Journal of the American Association for Laboratory Animal Science : JAALAS·2024

Search research articles

Related Experiment Video

Updated: Jan 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients.

Chelsea B Greenberg¹, Mark A Suckow^2,3, Ryan M Clauson⁴

¹Private Consultant, Salt Lake City, UT, U.S.A.

Anticancer Research

|September 26, 2025

Summary

Autologous cancer vaccines (ACVs) offer personalized cancer treatment by targeting unique tumor antigens. These veterinary ACVs are well-tolerated and show promise in improving outcomes for pets with cancer.

Keywords:

Autologous cancer vaccine chemoimmunotherapy comparative medicine neoantigens precision medicine review tumor specific antigens

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: Jan 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

Veterinary Medicine
Immunotherapy
Oncology

Background:

Precision medicine tailors treatments to individual patients.
Autologous cancer vaccines (ACVs) utilize patient-specific tumor antigens.
ACVs are adaptable for various cancer types and animal species.

Purpose of the Study:

To evaluate the role and efficacy of autologous cancer vaccines (ACVs) in veterinary precision medicine.
To explore the application of ACVs in companion animals like dogs, cats, and horses.
To assess the safety and potential of ACVs in comparative oncology.

Main Methods:

Review of historical ACV studies in veterinary medicine over 50 years.
Analysis of ACV integration into treatment protocols, including chemoimmunotherapy and combination with immune checkpoint inhibitors.
Evaluation of patient outcomes and tolerance across different animal species and ACV formulations.

Main Results:

ACVs have demonstrated improved patient outcomes in dogs, cats, and horses.
Successful application of ACVs in canine lymphoma and high-grade glioma treatment protocols.
ACVs are generally well-tolerated across various formulations and animal species.

Conclusions:

Autologous cancer vaccines (ACVs) represent a significant advancement in veterinary cancer immunotherapy.
ACVs are a viable component of precision medicine for companion animals.
Further opportunities exist for ACVs in comparative oncology and commercial development.